Advances in quantitative biomarker development have accelerated new forms of data-driven
insights for patients with cancer. However, most approaches are limited to a single mode of …

… Author contributions: Katharina Boehm had full access to all the data in the study and
takes responsibility for the integrity of the data and the accuracy of the data analysis. …

Background. Breast cancer is one of the most common types of cancer. However, only a few
trials assess the effects of arts therapies. Material and Methods. We searched the Cochrane …

For more than half a century, researchers around the world have been engaged in attempts
to achieve fusion ignition as a proof of principle of various fusion concepts. Following the …

Purpose We previously reported that four cycles of docetaxel/cyclophosphamide (TC)
produced superior disease-free survival (DFS) compared with four cycles of doxorubicin/…

Purpose The combination of doxorubicin and cyclophosphamide (AC) is a standard adjuvant
chemotherapy regimen. Studies of docetaxel and cyclophosphamide (TC) in metastatic …

We have used RNA in situ hybridization to study the regional expression of the Huntington's
disease gene (HD) and its rat homologue in brain and selected nonneural tissues. The HD …

Immunotherapy is used to treat almost all patients with advanced non-small cell lung cancer
(NSCLC); however, identifying robust predictive biomarkers remains challenging. Here we …

… Slides were then coated with Ilford K.2 nuclear track emulsion and left at -20C for 3 wk. …
Boehm, and Jong K. Yun for excellent technical assistance;and Suzanne Hazan for editorial …

Patients with high-grade serous ovarian cancer suffer poor prognosis and variable response
to treatment. Known prognostic factors for this disease include homologous recombination …